MBXBF (Microbix Biosystems) Inventories, Finished Goods: $4.06 Mil (As of Mar. 2026)


MBXBF Microbix Biosystems Inc MBXBF
55 GF Score
Price $0.22
GF Value $0.18
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Microbix Biosystems Inventories, Finished Goods?

Microbix Biosystems MBXBF -0.41% 55 Inventories, Finished Goods is $4.06 Mil as of Mar. 2026. GuruFocus rates MBXBF with a GF Score™ of 55/100 and a GF Value™ of $0.18 (Modestly Overvalued). The stock has 8 warning signs investors should review.

Microbix Biosystems's quarterly finished goods increased from Sep. 2025 ($3.43 Mil) to Dec. 2025 ($3.54 Mil) and increased from Dec. 2025 ($3.54 Mil) to Mar. 2026 ($4.06 Mil).

Microbix Biosystems's annual finished goods increased from Sep. 2023 ($1.60 Mil) to Sep. 2024 ($1.88 Mil) and increased from Sep. 2024 ($1.88 Mil) to Sep. 2025 ($3.43 Mil).

Microbix Biosystems Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Microbix Biosystems's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microbix Biosystems Inventories, Finished Goods Chart

Microbix Biosystems Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.29 1.85 1.60 1.88 3.43

Microbix Biosystems Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.32 3.04 3.43 3.54 4.06
MBXBF
55GF Score
Microbix Biosystems Inc MBXBF
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Microbix Biosystems Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of $4.06 Mil mean?
Microbix Biosystems (MBXBF) has a Inventories, Finished Goods of $4.06 Mil as of Mar. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on Microbix Biosystems and its competitors.
Is Microbix Biosystems' Inventories, Finished Goods too high?
Microbix Biosystems' current Inventories, Finished Goods is $4.06 Mil. Overall, Microbix Biosystems has a GF Score™ of 55/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Microbix Biosystems' Inventories, Finished Goods compare to VRTX and REGN?
Microbix Biosystems' Inventories, Finished Goods of $4.06 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Biotechnology company?
A good Inventories, Finished Goods depends on the Biotechnology industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Microbix Biosystems and its competitors. Microbix Biosystems's current Inventories, Finished Goods is $4.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microbix Biosystems stock overvalued right now?
Based on GuruFocus' analysis, Microbix Biosystems (MBXBF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.18, compared to a current price of $0.22 — trading 19.4% above its estimated fair value. The current Inventories, Finished Goods is $4.06 Mil. Microbix Biosystems' overall GF Score™ is 55/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Microbix Biosystems (MBXBF), the current Inventories, Finished Goods is $4.06 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Microbix Biosystems (MBXBF) Overvalued in 2026?

Based on GuruFocus' analysis, Microbix Biosystems stock appears to be overvalued. The current stock price of $0.22 is trading 19.4% above its estimated GF Value™ of $0.18. GuruFocus considers Microbix Biosystems to be Modestly Overvalued.

Key valuation signals for MBXBF:

  • Inventories, Finished Goods: $4.06 Mil
  • GF Value™: $0.18 vs. price of $0.22 (19.4% above fair value)
  • GF Score™: 55/100 with 8 warning signs

No single metric tells the full story. See the MBXBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Microbix Biosystems Business Description

Other Exchanges MBX:Canada
Address 265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3
Microbix Biosystems Inc develops biological products and technologies. There are two operating segments: The development, manufacturing, and sale of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows, and viral transport medium to enable collection of patient test samples; and the development and commercialization of novel and proprietary products or technologies such as Kinlytic. Geographically, it derives a majority of revenue from North America and also operates in Europe and other foreign countries.
55GF Score

Get the complete analysis for MBXBF

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.22
Price
$0.18
GF Value